fexofenadiene

# fexofenadine ## Overview - **Classification**: Second-generation H1-receptor antagonist (Antihistamine) - **Mechanism**: Selectively blocks peripheral H1-receptors, preventing histamine's effects without significant anticholinergic or sedative activity. ## Primary Indications 1. **Seasonal Allergic Rhinitis (SAR)** - Relief of symptoms including sneezing, rhinorrhea, itchy nose/palate/throat, itchy/watery/red eyes. 2. **Chronic Idiopathic Urticaria (CIU)** - Treatment of uncomplicated skin manifestations of chronic idiopathic urticaria. ## Adult Dosing ### Standard Dosing **Seasonal Allergic Rhinitis (SAR)** - **Dose**: **180 mg** - **Frequency**: Once daily (QD) - **Route**: Oral - **Duration**: As needed for symptoms **Chronic Idiopathic Urticaria (CIU)** - **Dose**: **180 mg** - **Frequency**: Once daily (QD) - **Route**: Oral ### Dose Adjustments - **Renal Impairment**: No specific dose adjustment generally needed based on CrCl for mild-moderate impairment. For **CrCl <10 mL/min**, consider **60 mg QD** due to increased exposure. - **Hepatic Impairment**: No specific dose adjustment recommended. - **Elderly Patients**: No dose adjustment typically required. Use caution if underlying renal impairment exists. ## Pediatric Dosing ### Neonates (0-28 days) - Fexofenadine is **not recommended** for this age group due to lack of safety and efficacy data. ### Infants (1-12 months) - Fexofenadine is generally **not recommended** for children under 6 months of age. - **Chronic Idiopathic Urticaria (CIU) - Age 6 months to <2 years** - **Dose**: **15 mg** (2.5 mL oral suspension) - **Frequency**: Twice daily (BID) - **Maximum**: **30 mg/day** - **Special Notes**: Use oral suspension. Limited data for allergic rhinitis in this age group. ### Children (1-12 years) - **Seasonal Allergic Rhinitis (SAR) or Chronic Idiopathic Urticaria (CIU) - Age 2 to 11 years** - **Dose**: **30 mg** (5 mL oral suspension or tablet) - **Frequency**: Twice daily (BID) - **Maximum**: **60 mg/day** - **Special Notes**: Oral suspension preferred for younger children. ### Adolescents (13-18 years) - **Seasonal Allergic Rhinitis (SAR) or Chronic Idiopathic Urticaria (CIU)** - **Dose**: Follow adult dosing guidelines (e.g., **180 mg QD** for SAR/CIU, or **60 mg BID** for SAR if preferred). - **Maximum**: **180 mg/day** ## Safety Information ### Contraindications - **Absolute**: Known hypersensitivity to fexofenadine or any component of the formulation. ### Common Adverse Effects - **Common (1-10%)**: Headache, fatigue, dizziness, nausea. - **Less Common (<1%)**: Dyspepsia, viral infection (URTI), cough. - **Serious but Rare**: Anaphylaxis, angioedema (rare). ### Key Drug Interactions - **Aluminum/Magnesium-containing Antacids**: Concurrent use may decrease fexofenadine absorption. Separate administration by **2 hours**. - **Erythromycin/Ketoconazole**: May increase fexofenadine plasma concentrations. Monitor for increased adverse effects, though clinical significance is usually minimal. - **Fruit Juices (e.g., grapefruit, orange, apple)**: May significantly reduce fexofenadine bioavailability. Avoid taking with fruit juices. ## Monitoring & Follow-up - **Before Treatment**: No specific laboratory tests required. - **During Treatment**: Monitor for symptomatic relief and adverse effects. - **Clinical Signs**: Watch for persistent or worsening symptoms. ## Clinical Pearls - 💡 **Tip 1**: Advise patients to take fexofenadine with water, not fruit juice, to avoid reduced absorption. - 💡 **Tip 2**: Fexofenadine is a non-sedating antihistamine; it generally causes less drowsiness than first-generation agents. - 💡 **Tip 3**: Take antacids containing aluminum or magnesium at least 2 hours before or after fexofenadine. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.